Odysight.ai FY26 operating loss widens 10% to $9.87 million; revenue drops 79% to $502,000 in six months ended June 30
ODYS•Expenses and cash use
Sales and marketing expense climbed 84% to USD 1.88 million as global selling expanded, while R&D edged down 1% to USD 4.8 million.
Operating cash outflow increased to USD 8.71 million from the prior-year period; cash and cash equivalents plus short-term deposits totaled USD 17.6 million at June 30, 2026.
Backlog and capital program
Backlog rose to about USD 14.1 million from end-2025; an at-the-market program allows up to USD 20 million of stock sales, with none sold.
Six-month loss widens as revenue falls
Odysight.ai posted a six-month operating loss of USD 9.87 million, widening 10% from the prior-year period.
Six-month revenue fell 79% to USD 502,000, reflecting no contribution from a Fortune 500 medical-company arrangement and a USD 1.69 million liability derecognition.
